Table of Content

1 Adalimumab Injection Market Overview
1.1 Product Overview and Scope of Adalimumab Injection
1.2 Adalimumab Injection Segment by Type
1.2.1 Global Adalimumab Injection Market Value Comparison by Type (2024-2034)
1.2.2 40mg/0.8ml
1.2.3 20mg/0.4ml
1.3 Adalimumab Injection Segment by Application
1.3.1 Global Adalimumab Injection Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Adalimumab Injection Market Size Estimates and Forecasts
1.4.1 Global Adalimumab Injection Revenue 2018-2029
1.4.2 Global Adalimumab Injection Sales 2018-2029
1.4.3 Global Adalimumab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Adalimumab Injection Market Competition by Manufacturers
2.1 Global Adalimumab Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Adalimumab Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Adalimumab Injection Average Price by Manufacturers (2018-2024)
2.4 Global Adalimumab Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Adalimumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adalimumab Injection, Product Type & Application
2.7 Adalimumab Injection Market Competitive Situation and Trends
2.7.1 Adalimumab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Adalimumab Injection Players Market Share by Revenue
2.7.3 Global Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Adalimumab Injection Retrospective Market Scenario by Region
3.1 Global Adalimumab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Adalimumab Injection Global Adalimumab Injection Sales by Region: 2018-2029
3.2.1 Global Adalimumab Injection Sales by Region: 2018-2024
3.2.2 Global Adalimumab Injection Sales by Region: 2024-2029
3.3 Global Adalimumab Injection Global Adalimumab Injection Revenue by Region: 2018-2029
3.3.1 Global Adalimumab Injection Revenue by Region: 2018-2024
3.3.2 Global Adalimumab Injection Revenue by Region: 2024-2029
3.4 North America Adalimumab Injection Market Facts & Figures by Country
3.4.1 North America Adalimumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Adalimumab Injection Sales by Country (2018-2029)
3.4.3 North America Adalimumab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adalimumab Injection Market Facts & Figures by Country
3.5.1 Europe Adalimumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Adalimumab Injection Sales by Country (2018-2029)
3.5.3 Europe Adalimumab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adalimumab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Adalimumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Adalimumab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Adalimumab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adalimumab Injection Market Facts & Figures by Country
3.7.1 Latin America Adalimumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Adalimumab Injection Sales by Country (2018-2029)
3.7.3 Latin America Adalimumab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adalimumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Adalimumab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Adalimumab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Adalimumab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adalimumab Injection Sales by Type (2018-2029)
4.1.1 Global Adalimumab Injection Sales by Type (2018-2024)
4.1.2 Global Adalimumab Injection Sales by Type (2024-2029)
4.1.3 Global Adalimumab Injection Sales Market Share by Type (2018-2029)
4.2 Global Adalimumab Injection Revenue by Type (2018-2029)
4.2.1 Global Adalimumab Injection Revenue by Type (2018-2024)
4.2.2 Global Adalimumab Injection Revenue by Type (2024-2029)
4.2.3 Global Adalimumab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Adalimumab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Adalimumab Injection Sales by Application (2018-2029)
5.1.1 Global Adalimumab Injection Sales by Application (2018-2024)
5.1.2 Global Adalimumab Injection Sales by Application (2024-2029)
5.1.3 Global Adalimumab Injection Sales Market Share by Application (2018-2029)
5.2 Global Adalimumab Injection Revenue by Application (2018-2029)
5.2.1 Global Adalimumab Injection Revenue by Application (2018-2024)
5.2.2 Global Adalimumab Injection Revenue by Application (2024-2029)
5.2.3 Global Adalimumab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Adalimumab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AbbVie Adalimumab Injection Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Amgen Adalimumab Injection Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sandoz Adalimumab Injection Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Fresenius Kabi Adalimumab Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Corporation Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Biogen Adalimumab Injection Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 Celltrion
6.6.1 Celltrion Corporation Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Celltrion Adalimumab Injection Product Portfolio
6.6.5 Celltrion Recent Developments/Updates
6.7 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Corporation Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Cadila Pharmaceuticals Adalimumab Injection Product Portfolio
6.7.5 Cadila Pharmaceuticals Recent Developments/Updates
6.8 Bio-Thera Solutions, Ltd.
6.8.1 Bio-Thera Solutions, Ltd. Corporation Information
6.8.2 Bio-Thera Solutions, Ltd. Description and Business Overview
6.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Portfolio
6.8.5 Bio-Thera Solutions, Ltd. Recent Developments/Updates
6.9 Hisun Biopharmaceutical
6.9.1 Hisun Biopharmaceutical Corporation Information
6.9.2 Hisun Biopharmaceutical Description and Business Overview
6.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hisun Biopharmaceutical Adalimumab Injection Product Portfolio
6.9.5 Hisun Biopharmaceutical Recent Developments/Updates
6.10 Innovent Biologics
6.10.1 Innovent Biologics Corporation Information
6.10.2 Innovent Biologics Description and Business Overview
6.10.3 Innovent Biologics Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Innovent Biologics Adalimumab Injection Product Portfolio
6.10.5 Innovent Biologics Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Adalimumab Injection Description and Business Overview
6.11.3 Mylan Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Mylan Adalimumab Injection Product Portfolio
6.11.5 Mylan Recent Developments/Updates
6.12 Zydus Group
6.12.1 Zydus Group Corporation Information
6.12.2 Zydus Group Adalimumab Injection Description and Business Overview
6.12.3 Zydus Group Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Zydus Group Adalimumab Injection Product Portfolio
6.12.5 Zydus Group Recent Developments/Updates
6.13 Boehringer Ingelheim
6.13.1 Boehringer Ingelheim Corporation Information
6.13.2 Boehringer Ingelheim Adalimumab Injection Description and Business Overview
6.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Boehringer Ingelheim Adalimumab Injection Product Portfolio
6.13.5 Boehringer Ingelheim Recent Developments/Updates
6.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
6.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
6.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Description and Business Overview
6.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Portfolio
6.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.15 Shanghai Henlius Biotech
6.15.1 Shanghai Henlius Biotech Corporation Information
6.15.2 Shanghai Henlius Biotech Adalimumab Injection Description and Business Overview
6.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Shanghai Henlius Biotech Adalimumab Injection Product Portfolio
6.15.5 Shanghai Henlius Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adalimumab Injection Industry Chain Analysis
7.2 Adalimumab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adalimumab Injection Production Mode & Process
7.4 Adalimumab Injection Sales and Marketing
7.4.1 Adalimumab Injection Sales Channels
7.4.2 Adalimumab Injection Distributors
7.5 Adalimumab Injection Customers
8 Adalimumab Injection Market Dynamics
8.1 Adalimumab Injection Industry Trends
8.2 Adalimumab Injection Market Drivers
8.3 Adalimumab Injection Market Challenges
8.4 Adalimumab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Adalimumab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Adalimumab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Adalimumab Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Adalimumab Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Adalimumab Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Adalimumab Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Adalimumab Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Adalimumab Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Adalimumab Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Adalimumab Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adalimumab Injection, Product Type & Application
Table 12. Global Key Manufacturers of Adalimumab Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adalimumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adalimumab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Adalimumab Injection Sales Market Share by Region (2018-2024)
Table 19. Global Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Adalimumab Injection Sales Market Share by Region (2024-2029)
Table 21. Global Adalimumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Adalimumab Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Adalimumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Adalimumab Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Adalimumab Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Adalimumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Adalimumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Adalimumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Adalimumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Adalimumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Adalimumab Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Adalimumab Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Adalimumab Injection Sales Market Share by Type (2018-2024)
Table 53. Global Adalimumab Injection Sales Market Share by Type (2024-2029)
Table 54. Global Adalimumab Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Adalimumab Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Adalimumab Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Adalimumab Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Adalimumab Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Adalimumab Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Adalimumab Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Adalimumab Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Adalimumab Injection Sales Market Share by Application (2018-2024)
Table 63. Global Adalimumab Injection Sales Market Share by Application (2024-2029)
Table 64. Global Adalimumab Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Adalimumab Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Adalimumab Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Adalimumab Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Adalimumab Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Adalimumab Injection Price (US$/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. AbbVie Adalimumab Injection Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Amgen Adalimumab Injection Product
Table 79. Amgen Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sandoz Adalimumab Injection Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Fresenius Kabi Corporation Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Fresenius Kabi Adalimumab Injection Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Biogen Corporation Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Biogen Adalimumab Injection Product
Table 94. Biogen Recent Developments/Updates
Table 95. Celltrion Corporation Information
Table 96. Celltrion Description and Business Overview
Table 97. Celltrion Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Celltrion Adalimumab Injection Product
Table 99. Celltrion Recent Developments/Updates
Table 100. Cadila Pharmaceuticals Corporation Information
Table 101. Cadila Pharmaceuticals Description and Business Overview
Table 102. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Cadila Pharmaceuticals Adalimumab Injection Product
Table 104. Cadila Pharmaceuticals Recent Developments/Updates
Table 105. Bio-Thera Solutions, Ltd. Corporation Information
Table 106. Bio-Thera Solutions, Ltd. Description and Business Overview
Table 107. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bio-Thera Solutions, Ltd. Adalimumab Injection Product
Table 109. Bio-Thera Solutions, Ltd. Recent Developments/Updates
Table 110. Hisun Biopharmaceutical Corporation Information
Table 111. Hisun Biopharmaceutical Description and Business Overview
Table 112. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Hisun Biopharmaceutical Adalimumab Injection Product
Table 114. Hisun Biopharmaceutical Recent Developments/Updates
Table 115. Innovent Biologics Corporation Information
Table 116. Innovent Biologics Description and Business Overview
Table 117. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Innovent Biologics Adalimumab Injection Product
Table 119. Innovent Biologics Recent Developments/Updates
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Mylan Adalimumab Injection Product
Table 124. Mylan Recent Developments/Updates
Table 125. Zydus Group Corporation Information
Table 126. Zydus Group Description and Business Overview
Table 127. Zydus Group Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Zydus Group Adalimumab Injection Product
Table 129. Zydus Group Recent Developments/Updates
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Boehringer Ingelheim Adalimumab Injection Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Jiangsu Chia Tai-Tianqing Pharmaceutical Corporation Information
Table 136. Jiangsu Chia Tai-Tianqing Pharmaceutical Description and Business Overview
Table 137. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product
Table 139. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 140. Shanghai Henlius Biotech Corporation Information
Table 141. Shanghai Henlius Biotech Description and Business Overview
Table 142. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Shanghai Henlius Biotech Adalimumab Injection Product
Table 144. Shanghai Henlius Biotech Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Adalimumab Injection Distributors List
Table 148. Adalimumab Injection Customers List
Table 149. Adalimumab Injection Market Trends
Table 150. Adalimumab Injection Market Drivers
Table 151. Adalimumab Injection Market Challenges
Table 152. Adalimumab Injection Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Adalimumab Injection
Figure 2. Global Adalimumab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Adalimumab Injection Market Share by Type in 2022 & 2029
Figure 4. 40mg/0.8ml Product Picture
Figure 5. 20mg/0.4ml Product Picture
Figure 6. Global Adalimumab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Adalimumab Injection Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Adalimumab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Adalimumab Injection Market Size (2018-2029) & (US$ Million)
Figure 13. Global Adalimumab Injection Sales (2018-2029) & (K Units)
Figure 14. Global Adalimumab Injection Average Price (US$/Unit) & (2018-2029)
Figure 15. Adalimumab Injection Report Years Considered
Figure 16. Adalimumab Injection Sales Share by Manufacturers in 2022
Figure 17. Global Adalimumab Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Adalimumab Injection Players: Market Share by Revenue in 2022
Figure 19. Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Adalimumab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Adalimumab Injection Sales Market Share by Country (2018-2029)
Figure 22. North America Adalimumab Injection Revenue Market Share by Country (2018-2029)
Figure 23. United States Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Adalimumab Injection Sales Market Share by Country (2018-2029)
Figure 26. Europe Adalimumab Injection Revenue Market Share by Country (2018-2029)
Figure 27. Germany Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Adalimumab Injection Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Adalimumab Injection Revenue Market Share by Region (2018-2029)
Figure 34. China Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Adalimumab Injection Sales Market Share by Country (2018-2029)
Figure 42. Latin America Adalimumab Injection Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Adalimumab Injection Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Adalimumab Injection Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Adalimumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Adalimumab Injection by Type (2018-2029)
Figure 52. Global Revenue Market Share of Adalimumab Injection by Type (2018-2029)
Figure 53. Global Adalimumab Injection Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Adalimumab Injection by Application (2018-2029)
Figure 55. Global Revenue Market Share of Adalimumab Injection by Application (2018-2029)
Figure 56. Global Adalimumab Injection Price (US$/Unit) by Application (2018-2029)
Figure 57. Adalimumab Injection Value Chain
Figure 58. Adalimumab Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed